RxNorm Semantic Concepts Index - 233
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "233".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 23321 | Prostaglandin PGF2 alpha tromethamine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 23321 | Prostaglandin PGF2 alpha tromethamine | Designated preferred name (PT) | NO | |
| RxCUI: 23321 | Prostaglandin PGF2 alpha tromethamine | Full form of descriptor (FN) | NO | |
| RxCUI: 23321 | Prostaglandin PGF2 alpha tromethamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 233272 | bexarotene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 233272 | bexarotene | Designated preferred name (PT) | YES | |
| RxCUI: 233272 | bexarotene | Full form of descriptor (FN) | YES | |
| RxCUI: 233272 | bexarotene | Designated preferred name (PT) | YES | |
| RxCUI: 233272 | bexarotene | Full form of descriptor (FN) | YES | |
| RxCUI: 2333 | Chiniofon | Designated preferred name (PT) | NO | |
| RxCUI: 2333 | Chiniofon | Full form of descriptor (FN) | NO | |
| RxCUI: 233335 | Nicotianamine synthase | Designated preferred name (PT) | NO | |
| RxCUI: 233335 | Nicotianamine synthase | Full form of descriptor (FN) | NO | |
| RxCUI: 23337 | Dioscin | Designated preferred name (PT) | NO | |
| RxCUI: 23337 | Dioscin | Full form of descriptor (FN) | NO | |
| RxCUI: 233386 | Dexketoprofen trometamol | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 233386 | Dexketoprofen trometamol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 233386 | Dexketoprofen trometamol | Full form of descriptor (FN) | NO | |
| RxCUI: 233386 | Dexketoprofen trometamol | Designated preferred name (PT) | NO | |
| RxCUI: 23343 | Dioxathion | Designated preferred name (PT) | NO | |
| RxCUI: 23343 | Dioxathion | Full form of descriptor (FN) | NO | |
| RxCUI: 233455 | Debacterol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 23350 | dioxybenzone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 233562 | helicidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 233562 | helicidine | Designated preferred name (PT) | NO | |
| RxCUI: 233562 | helicidine | Full form of descriptor (FN) | NO | |
| RxCUI: 2336 | Chitin-UDP acetylglucosaminyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 2336 | Chitin-UDP acetylglucosaminyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 2336 | Chitin-UDP acetylglucosaminyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 23360 | Dipeptidyl carboxypeptidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 23360 | Dipeptidyl carboxypeptidase | Designated preferred name (PT) | NO | |
| RxCUI: 23360 | Dipeptidyl carboxypeptidase | Full form of descriptor (FN) | NO | |
| RxCUI: 233603 | clevidipine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 233603 | clevidipine | Designated preferred name (PT) | YES | |
| RxCUI: 233603 | clevidipine | Full form of descriptor (FN) | YES | |
| RxCUI: 233603 | clevidipine | Designated preferred name (PT) | YES | |
| RxCUI: 233603 | clevidipine | Full form of descriptor (FN) | YES | |
| RxCUI: 23361 | Cathepsin C | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 23361 | Cathepsin C | Designated preferred name (PT) | NO | |
| RxCUI: 23361 | Cathepsin C | Full form of descriptor (FN) | NO | |
| RxCUI: 23361 | Cathepsin C | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 23361 | Cathepsin C | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 23362 | Dipeptidyl-amino-peptidase II | Designated preferred name (PT) | NO | |
| RxCUI: 23362 | Dipeptidyl-amino-peptidase II | Full form of descriptor (FN) | NO | |
| RxCUI: 23362 | Dipeptidyl-amino-peptidase II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 233624 | N-Acetylneuraminate O^4^-acetyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 233624 | N-Acetylneuraminate O^4^-acetyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 23363 | Dipeptidyl-amino-peptidase III | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 23363 | Dipeptidyl-amino-peptidase III | Designated preferred name (PT) | NO | |
| RxCUI: 23363 | Dipeptidyl-amino-peptidase III | Full form of descriptor (FN) | NO | |
| RxCUI: 23363 | Dipeptidyl-amino-peptidase III | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 23363 | Dipeptidyl-amino-peptidase III | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 23364 | Diphemanil metilsulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 23364 | Diphemanil metilsulfate | Designated preferred name (PT) | NO | |
| RxCUI: 23364 | Diphemanil metilsulfate | Full form of descriptor (FN) | NO | |
| RxCUI: 23364 | Diphemanil metilsulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 23365 | Diphacinone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 23365 | Diphacinone | Designated preferred name (PT) | NO | |
| RxCUI: 23365 | Diphacinone | Full form of descriptor (FN) | NO | |
| RxCUI: 233698 | dronedarone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 233698 | dronedarone | Designated preferred name (PT) | YES | |
| RxCUI: 233698 | dronedarone | Full form of descriptor (FN) | YES | |
| RxCUI: 233698 | dronedarone | Designated preferred name (PT) | YES | |
| RxCUI: 233698 | dronedarone | Full form of descriptor (FN) | YES | |
| RxCUI: 23370 | Difenidol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 23370 | Difenidol | Full form of descriptor (FN) | NO | |
| RxCUI: 23370 | Difenidol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 23370 | Difenidol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 23370 | Difenidol | Designated preferred name (PT) | NO | |
| RxCUI: 23370 | Difenidol | Designated preferred name (PT) | NO | |
| RxCUI: 23370 | Difenidol | Full form of descriptor (FN) | NO | |
| RxCUI: 23371 | Diphenyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2338 | 1,4-beta-poly-N-acetylglucosaminidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2338 | 1,4-beta-poly-N-acetylglucosaminidase | Designated preferred name (PT) | NO | |
| RxCUI: 2338 | 1,4-beta-poly-N-acetylglucosaminidase | Full form of descriptor (FN) | NO | |
| RxCUI: 2338 | 1,4-beta-poly-N-acetylglucosaminidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2338 | 1,4-beta-poly-N-acetylglucosaminidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2338 | 1,4-beta-poly-N-acetylglucosaminidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 23386 | diphenylpyraline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 23386 | diphenylpyraline | Designated preferred name (PT) | NO | |
| RxCUI: 23386 | diphenylpyraline | Full form of descriptor (FN) | NO | |
| RxCUI: 23386 | diphenylpyraline | Designated preferred name (PT) | NO | |
| RxCUI: 23386 | diphenylpyraline | Full form of descriptor (FN) | NO | |
| RxCUI: 23387 | Diphenylthiourea | Designated preferred name (PT) | NO | |
| RxCUI: 23387 | Diphenylthiourea | Full form of descriptor (FN) | NO | |
| RxCUI: 23387 | Diphenylthiourea | Designated preferred name (PT) | NO | |
| RxCUI: 23387 | Diphenylthiourea | Full form of descriptor (FN) | NO | |
| RxCUI: 233872 | 5-oxoprolinase (adenosine triphosphate-hydrolysing) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 233872 | 5-oxoprolinase (adenosine triphosphate-hydrolysing) | Full form of descriptor (FN) | NO | |
| RxCUI: 233872 | 5-oxoprolinase (adenosine triphosphate-hydrolysing) | Designated preferred name (PT) | NO | |
| RxCUI: 233872 | 5-oxoprolinase (adenosine triphosphate-hydrolysing) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 233940 | Eberconazole | Designated preferred name (PT) | NO | |
| RxCUI: 233940 | Eberconazole | Full form of descriptor (FN) | NO | |
| RxCUI: 233940 | Eberconazole | Designated preferred name (PT) | NO | |
| RxCUI: 233940 | Eberconazole | Full form of descriptor (FN) | NO |